TrialCells2021

Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.

Stephane Oudard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.